Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is available
as soon as there are survivors. The COVID-19 pandemic represented the first large-scale …

Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is available
as soon as there are survivors. The COVID-19 pandemic represented the first large-scale …

… Our results suggest that convalescent plasma with adequate anti-SARS-CoV-2 antibody titer
is safe and has the potential for positive impact on clinical outcomes including recovery and …

… experience from China [4], convalescent plasma, old passive immunotherapy used with …
year, overall documenting that COVID-19 convalescent plasma (CCP), if administered at high-…

… COVID-19 convalescent plasma (CCP) was an early and widely adopted putative therapy
for severe COVID-19. Results from randomized control trials and observational studies have …

… In patients with COVID-19, there was no clear mortality benefit associated with convalescent
plasma treatment. In patients with mild disease, convalescent plasma did not prevent either …

… Convalescent plasma might be a potential treatment for COVID‐19.1 Convalescent plasma
refers to a plasma therapy based on plasma or plasma derivatives obtained from donors who …

… plasma therapy improves patient mortality. Until we have concrete evidence to prove otherwise,
convalescent plasma … for any conflicts that were resolved through mutual consultation. …

… Until now the number of COVID-19 patients with known outcomes of convalescent plasma
administration is particularly limited, stemming from 6 case series. The follow-up of cases …

… Because studies and reviews yielded conflicting results, there has been a persistent lack of
… effect of convalescent plasma treatment on the clinical outcomes of patients with COVID-19. …